Living With a Pacemaker or ICD

Cardiac implantable electronic devices — pacemakers and implantable cardioverter-defibrillators (ICDs) — are placed in hundreds of thousands of patients in the United States each year to manage conditions ranging from bradycardia to life-threatening ventricular arrhythmias. Understanding how these devices function, what daily life looks like after implantation, and where regulatory and clinical boundaries apply is essential for patients and caregivers navigating long-term cardiac management. This page covers device types, operational mechanics, common real-world scenarios, and the decision boundaries that govern device programming and lifestyle adjustments. For a broader orientation to cardiac care in the United States, the Cardiology Authority resource covers the full scope of cardiovascular medicine.

Definition and scope

A pacemaker is an implanted device that delivers low-energy electrical pulses to maintain an adequate heart rate when the heart's intrinsic conduction system fails to do so reliably. An implantable cardioverter-defibrillator (ICD) detects and terminates life-threatening arrhythmias — primarily ventricular fibrillation and ventricular tachycardia — through high-energy shocks and, in modern devices, backup pacing.

The U.S. Food and Drug Administration (FDA) classifies both device types as Class III medical devices under 21 CFR Part 870, requiring premarket approval (PMA) before commercial distribution (FDA Device Classification). The Heart Rhythm Society (HRS) publishes clinical practice guidelines that define the specific arrhythmia diagnoses and functional criteria that justify implantation, most recently updated in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA).

A key classification boundary exists between the two device categories:

A third variant, cardiac resynchronization therapy (CRT), adds a third lead to coordinate left and right ventricular contraction and is deployed as either a CRT-P (pacing only) or CRT-D (with defibrillation). CRT is indicated in select heart failure populations with reduced ejection fraction and wide QRS duration, per ACC/AHA heart failure guidelines. Detailed clinical criteria for the ICD are covered separately at Implantable Cardioverter-Defibrillators, while pacemaker indications are addressed at Pacemakers.

How it works

Both device types share a common hardware architecture: a hermetically sealed pulse generator containing a battery and circuitry, connected to one or more transvenous leads implanted in cardiac chambers, or — in newer leadless designs — a self-contained capsule anchored directly to the endocardium.

Pacemaker operational modes follow the NASPE/BPEG (North American Society of Pacing and Electrophysiology / British Pacing and Electrophysiology Group) generic code, a five-letter designation still in clinical use. The most common programmed mode in ambulatory patients is DDDR — dual-chamber sensing and pacing, with rate-responsive adaptation based on a motion or minute-ventilation sensor.

ICD therapy hierarchy is programmed in discrete zones based on detected heart rate:

  1. Monitor zone — rate detected but no therapy delivered; data logged for review.
  2. ATP zone — rapid burst or ramp pacing attempts to interrupt ventricular tachycardia without shock delivery.
  3. Shock zone — synchronized cardioversion or unsynchronized defibrillation for ventricular fibrillation or very fast ventricular tachycardia.

Remote monitoring, now standard across major device platforms, transmits device diagnostics nightly or on-demand to a secure clinic server. The HRS published a consensus statement on remote monitoring in 2015 confirming its role in reducing time to clinical decision-making and detecting lead integrity issues earlier than scheduled in-office checks.

Battery longevity varies by device type, pacing dependency, and programming: pacemaker batteries typically last 8–12 years, while ICD batteries, which must sustain high-voltage capacitors, typically last 5–8 years. Generator replacement is a distinct surgical procedure performed electively as battery depletion is projected.

Common scenarios

Electromagnetic interference (EMI) is the most frequently encountered environmental consideration. Most consumer electronics — including smartphones, induction cooktops, and standard anti-theft security gates — pose negligible risk at normal use distances, as confirmed by FDA device labeling requirements and device manufacturer IFUs (instructions for use). Industrial arc-welding equipment, MRI scanners (with non-MRI-conditional devices), and certain surgical energy devices (electrocautery) present higher risk and require device-specific protocols.

MRI-conditional pacemakers and ICDs cleared by the FDA after approximately 2011 can undergo 1.5-tesla MRI scanning under defined conditions, including specific programming modes during the scan. Patients with older non-conditional devices require individualized risk-benefit analysis coordinated between the ordering physician and the implanting electrophysiologist.

Driving restrictions following ICD implantation are governed partly by state motor vehicle regulations and partly by clinical guidelines. The ACC/AHA and HRS joint guidance recommends a minimum 3-month driving restriction following ICD implantation for primary prevention indications, and a restriction period of at least 6 months following an appropriate shock for secondary prevention — though state laws vary and supersede clinical recommendations in the legal sense. The regulatory context for cardiology page addresses the intersection of federal and state authority over cardiac device management.

Air travel does not affect device function. Walk-through metal detectors at airports can be triggered by device hardware but do not alter programming; hand-held wands should not be held directly over the device for prolonged periods. Body scanners (millimeter-wave) are generally considered safe per FDA communications.

Physical activity is encouraged within parameters set by the treating electrophysiologist. Rate-responsive pacemakers adapt output to exercise demand, and most ICD recipients return to moderate aerobic activity. Sustained high-intensity exercise programs should be reviewed against device programming thresholds to avoid inappropriate shock delivery from exercise-induced sinus tachycardia entering a programmed detection zone.

Decision boundaries

Four structured decision domains govern ongoing device management:

  1. Reprogramming thresholds — Detection rates and therapy zones are adjusted at follow-up based on arrhythmia burden logs, inappropriate therapy episodes, and changes in the patient's clinical condition. No single universal programming parameter applies across all patients.

  2. Generator replacement timing — Elective replacement indicators (ERI) appear on device interrogation when battery voltage reaches a manufacturer-defined level, typically providing 3–6 months before end of service (EOS). Replacement before EOS is the clinical standard.

  3. Lead management — Lead failure (fracture, insulation breach, dislodgement) may require revision, extraction, or addition of a new lead. Transvenous lead extraction is a high-risk procedure classified by HRS as requiring specific operator and center volume thresholds, per the 2017 HRS Expert Consensus Statement on Lead Removal.

  4. Device deactivation decisions — At end of life or in the setting of a patient's informed refusal of further treatment, ICD deactivation is ethically and legally permissible. The AHA and HRS have each published position statements affirming that deactivation of an ICD, including the shock function, is consistent with established bioethical and legal standards regarding withdrawal of unwanted medical treatment. Deactivation does not require judicial review and can be performed by a device clinic in response to a competent patient's documented request.

Patients with implanted devices are encouraged to carry device identification cards issued by the manufacturer at implant, which specify device model, lead models, implant date, implanting facility, and MRI conditionality status.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)